133 related articles for article (PubMed ID: 28108875)
1. Against the Odds: Syringe Exchange Policy Implementation in Indiana.
Meyerson BE; Lawrence CA; Miller L; Gillespie A; Raymond D; Kelley K; Shannon DJ
AIDS Behav; 2017 Apr; 21(4):973-981. PubMed ID: 28108875
[TBL] [Abstract][Full Text] [Related]
2. Ideological Anachronism Involving Needle and Syringe Exchange Programs: Lessons From the Indiana HIV Outbreak.
Rich JD; Adashi EY
JAMA; 2015 Jul; 314(1):23-4. PubMed ID: 26000661
[No Abstract] [Full Text] [Related]
3. Operational issues in syringe exchanges: the New York City tagging alternative study.
Paone D; Des Jarlais DC; Caloir S; Clark J; Jose B
J Community Health; 1995 Apr; 20(2):111-23. PubMed ID: 7642778
[TBL] [Abstract][Full Text] [Related]
4. Operating needle exchange programmes in the hills of Thailand.
Gray J
AIDS Care; 1995; 7(4):489-99. PubMed ID: 8547363
[TBL] [Abstract][Full Text] [Related]
5. Syringe exchange in Canada: good but not enough to stem the HIV tide.
Hankins CA
Subst Use Misuse; 1998 Apr; 33(5):1129-46. PubMed ID: 9596380
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of a pilot study on needle and syringe exchange program among injecting drug users in a community in Guangdong, China].
Lin P; Fan ZF; Yang F; Wu ZY; Wang Y; Liu YY; Ming ZQ; Li WJ; Luo W; Fu XB; Mai XR; Xu RH; Feng WY; He Q
Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Sep; 38(5):305-8. PubMed ID: 15498241
[TBL] [Abstract][Full Text] [Related]
7. Guidelines for better harm reduction: evaluating implementation of best practice recommendations for needle and syringe programs (NSPs).
Strike C; Watson TM; Lavigne P; Hopkins S; Shore R; Young D; Leonard L; Millson P
Int J Drug Policy; 2011 Jan; 22(1):34-40. PubMed ID: 20413288
[TBL] [Abstract][Full Text] [Related]
8. Structural impediments to operational syringe-exchange programs.
Heimer R; Bluthenthal RN; Singer M; Khoshnood K
AIDS Public Policy J; 1996; 11(4):169-84. PubMed ID: 10915251
[No Abstract] [Full Text] [Related]
9. Non-prescription syringe sales in California: a qualitative examination of practices among 12 local health jurisdictions.
Rose VJ; Backes G; Martinez A; McFarland W
J Urban Health; 2010 Jul; 87(4):561-75. PubMed ID: 20405227
[TBL] [Abstract][Full Text] [Related]
10. Access to syringes in three Russian cities: implications for syringe distribution and coverage.
Sarang A; Rhodes T; Platt L
Int J Drug Policy; 2008 Apr; 19 Suppl 1():S25-36. PubMed ID: 18313910
[TBL] [Abstract][Full Text] [Related]
11. The evidence does not speak for itself: The role of research evidence in shaping policy change for the implementation of publicly funded syringe exchange programs in three US cities.
Allen ST; Ruiz MS; O'Rourke A
Int J Drug Policy; 2015 Jul; 26(7):688-95. PubMed ID: 25979789
[TBL] [Abstract][Full Text] [Related]
12. Public funding of US syringe exchange programs.
Des Jarlais DC; McKnight C; Milliken J
J Urban Health; 2004 Mar; 81(1):118-21. PubMed ID: 15047790
[TBL] [Abstract][Full Text] [Related]
13. Approval of syringe exchange programs in California: results from a local approach to HIV prevention.
Bluthenthal RN; Heinzerling KG; Anderson R; Flynn NM; Kral AH
Am J Public Health; 2008 Feb; 98(2):278-83. PubMed ID: 17538068
[TBL] [Abstract][Full Text] [Related]
14. Syringe exchange in Germany.
Weber U; Schneider W
Subst Use Misuse; 1998 Apr; 33(5):1093-112. PubMed ID: 9596378
[TBL] [Abstract][Full Text] [Related]
15. Preventing HIV and Hepatitis Infections Among People Who Inject Drugs: Leveraging an Indiana Outbreak Response to Break the Impasse.
Crowley JS; Millett GA
AIDS Behav; 2017 Apr; 21(4):968-972. PubMed ID: 28220312
[TBL] [Abstract][Full Text] [Related]
16. As easy as ESAP. The New York State Expanded Syringe Access Demonstration Program.
Shotsky WJ; Cooper JG; Klein SJ
Body Posit; 2003; 16(1):15-7. PubMed ID: 12739507
[No Abstract] [Full Text] [Related]
17. Using Interrupted Time Series Analysis to Measure the Impact of Legalized Syringe Exchange on HIV Diagnoses in Baltimore and Philadelphia.
Ruiz MS; OʼRourke A; Allen ST; Holtgrave DR; Metzger D; Benitez J; Brady KA; Chaulk CP; Wen LS
J Acquir Immune Defic Syndr; 2019 Dec; 82 Suppl 2(2):S148-S154. PubMed ID: 31658203
[TBL] [Abstract][Full Text] [Related]
18. Syringe availability as HIV prevention: a review of modalities.
Coffin P
J Urban Health; 2000 Sep; 77(3):306-30. PubMed ID: 10976607
[TBL] [Abstract][Full Text] [Related]
19. The feasibility of a syringe-needle-exchange program in Vietnam.
Quan VM; Chung A; Abdul-Quader AS
Subst Use Misuse; 1998 Apr; 33(5):1055-67. PubMed ID: 9596375
[TBL] [Abstract][Full Text] [Related]
20. Drug use and harm reduction policy: alternative perspectives on the California proposal.
Stauffer L
J Health Soc Policy; 2004; 19(3):19-36. PubMed ID: 15829451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
